WHO ICTRP trial
Evaluating the effect of sildenafil on the treatment of severe asthma
IRCT20140518017738N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20140518017738N2 |
|---|---|
| Public title | Evaluating the effect of sildenafil on the treatment of severe asthma |
| Scientific title | The effect of sildenafil on improvement of lung function and asthma attacks in patients with severe asthma |
| Primary sponsor | Ahvaz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Asthma. Asthma |
| Interventions | Intervention 1: Intervention group: This group received a single 50 mg dose of oral sildenafil (made in Ahvaz pharmacy faculty) daily during one month. Intervention 2: Control group: This group received a single 50 mg dose of oral placebo… |
| Registration date | Apr 8, 2019 |
| Target size | 20 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: